--- title: Profil:为糖尿病和肥胖症研究提供全方位服务的CRO description: Profil作为一家提供全方位服务的CRO，将科学勤勉与职业操守相结合，专注于糖尿病和肥胖症研究。 --- [![profil-logo-wortbild-with claim-4c-offset_1000px-1](https://www.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px-1.png?width=1000&name=profil-logo-wortbild-with%20claim-4c-offset_1000px-1.png "profil-logo-wortbild-with claim-4c-offset_1000px-1")](https://www.profil.com?hsLang=zh) [![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da) [Patient information](https://www.profil.de) ![Organization Header](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x400px_Organization.jpg?width=1077&height=400&name=Header_1077x400px_Organization.jpg) # 公司组织 Profil：为糖尿病和肥胖症研究提供全方位服务的CRO ### 关于 Profil 了解Profil的历史和能力。 [更多内容](https://www.profil.com/organization/about-profil?hsLang=zh) ### 人员 认识创立Profil的科学家 [更多内容](https://www.profil.com/organization/people?hsLang=zh) ### 桥接研究 现日本桥接研究的价值。 [更多内容](https://www.profil.com/services/bridging-study?hsLang=zh) ### 网络研讨会 网络研讨会点播: "ClampArt®: Next Generation Glucose Clamps"   [![立即观看](https://no-cache.hubspot.com/cta/default/481167/01a9db45-f198-4207-8f73-9dd5c74a998a.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/01a9db45-f198-4207-8f73-9dd5c74a998a)   ## Profil为糖尿病和肥胖症的早期临床试验提供专业内容 Profil是一家为糖尿病和肥胖症早期临床试验提供全方位服务的CRO。这意味着我们能够为客户提供科学和监管方面的专业内容，以及所有成功完成糖尿病临床研究和治疗所需的服务内容。我们将与您一起开发尖端的实验方法，优化研究设计，并为进一步的化合物开发提供关键答案。 通过在同行评审期刊上发表的360多篇论文，Profil的专家们在理解糖尿病、肥胖症和营养学以及医疗技术进步方面做出的贡献获得了国际认可。 探索Profil：什么使我们与众不同，我们的科学家是谁。 [![Download our company brochure](https://no-cache.hubspot.com/cta/default/481167/87c15d66-f9a7-4f3e-aa1e-e17c94915691.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/87c15d66-f9a7-4f3e-aa1e-e17c94915691) ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_References.png?width=49&height=49&name=Icon_References.png) #### References We have published with the following sponsors: ![Referenzen](https://www.profil.com/hubfs/BLUE_MOON/content-bilder/Referenzen.gif "Referenzen") [View more](https://www.profil.com/knowledge-center/references?hsLang=zh) ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_Certificates.png?width=44&height=49&name=Icon_Certificates.png) #### Certificates | ![13485_Zertifikatssiegel_black_A3](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_134852016_certificate_blue.png) ISO 13485:2016 ![27001_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_27001_certificate_.png) ISO 27001 | ![9001:2015_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_9001-2015_certificate.png) ISO 9001:2015 ![9001:2015_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/BVMA_Logo_Certificate_size.png) BVMA Member | | --- | --- | ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_Publications.png?width=44&height=49&name=Icon_Publications.png) #### Publications Marquard J. et al., 2015. Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment. Nature Medicine 21, 363–372 (2015). [View all](https://www.profil.com/knowledge-center/publications?hsLang=zh) Profil Institut für Stoffwechselforschung GmbH (Neuss, Nordrhein-Westfalen) stands as an unrivalled full-service contract research organization for diabetes and obesity research and medical technology development. ###### Profil Institut für Stoffwechselforschung GmbH Hellersbergstraße 9 · 41460 - Neuss, Germany Telefon +49-2131-4018-345 · marketing@profil.com [Imprint](https://www.profil.com/imprint?hsLang=zh) | [Privacy Policy](https://www.profil.com/privacy?hsLang=zh)